Autolus Therapeutics plc Net Asset Quality Index
Autolus Therapeutics plc net asset quality index. Autolus Therapeutics plc (6A3A) has a Net Asset Quality Index of 15.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €493.23 Million minus total liabilities of €418.39 Million yields net assets of €74.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 6A3A net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Autolus Therapeutics plc (2017–2025)
Net asset quality index of Autolus Therapeutics plc from 2017 to 2025. This chart shows how Autolus Therapeutics plc's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 15.2%, representing net assets of €74.84 Million against total assets of €493.23 Million EUR. Check 6A3A strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Autolus Therapeutics plc Net Asset Quality Index by Year (2017–2025)
Autolus Therapeutics plc net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Autolus Therapeutics plc from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Autolus Therapeutics plc.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 30.2% | €178.13 Million | €589.07 Million | €410.94 Million | ▼ -24.4 pp |
| 2024 | 54.6% | €427.32 Million | €782.73 Million | €355.40 Million | ▲ +24.9 pp |
| 2023 | 29.7% | €111.47 Million | €375.38 Million | €263.91 Million | ▼ -31.2 pp |
| 2022 | 60.9% | €298.67 Million | €490.27 Million | €191.60 Million | ▼ -16.3 pp |
| 2021 | 77.3% | €313.32 Million | €405.56 Million | €92.24 Million | ▲ +5.9 pp |
| 2020 | 71.4% | €210.03 Million | €294.24 Million | €84.20 Million | ▼ -12.6 pp |
| 2019 | 84.0% | €254.84 Million | €303.53 Million | €48.69 Million | ▼ -9.5 pp |
| 2018 | 93.5% | €255.47 Million | €273.20 Million | €17.74 Million | ▼ -2.4 pp |
| 2017 | 95.9% | €142.60 Million | €148.66 Million | €6.06 Million | — |